Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1270

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.
In 2018, the global Neuroscience Antibodies and Assays market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Neuroscience Antibodies and Assays status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuroscience Antibodies and Assays development in United States, Europe and China.

The key players covered in this study
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens

Market segment by Type, the product can be split into
Consumables
Instruments

Market segment by Application, split into
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Neuroscience Antibodies and Assays status, future forecast, growth opportunity, key market and key players.
To present the Neuroscience Antibodies and Assays development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neuroscience Antibodies and Assays are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (2014-2025)
1.4.2 Consumables
1.4.3 Instruments
1.5 Market by Application
1.5.1 Global Neuroscience Antibodies and Assays Market Share by Application (2014-2025)
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Academic & Research Institutes
1.5.4 Hospitals & Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Neuroscience Antibodies and Assays Market Size
2.2 Neuroscience Antibodies and Assays Growth Trends by Regions
2.2.1 Neuroscience Antibodies and Assays Market Size by Regions (2014-2025)
2.2.2 Neuroscience Antibodies and Assays Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Neuroscience Antibodies and Assays Market Size by Manufacturers
3.1.1 Global Neuroscience Antibodies and Assays Revenue by Manufacturers (2014-2019)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.2 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.3 Key Players Neuroscience Antibodies and Assays Product/Solution/Service
3.4 Date of Enter into Neuroscience Antibodies and Assays Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Neuroscience Antibodies and Assays Market Size by Type (2014-2019)
4.2 Global Neuroscience Antibodies and Assays Market Size by Application (2014-2019)

5 United States
5.1 United States Neuroscience Antibodies and Assays Market Size (2014-2019)
5.2 Neuroscience Antibodies and Assays Key Players in United States
5.3 United States Neuroscience Antibodies and Assays Market Size by Type
5.4 United States Neuroscience Antibodies and Assays Market Size by Application

6 Europe
6.1 Europe Neuroscience Antibodies and Assays Market Size (2014-2019)
6.2 Neuroscience Antibodies and Assays Key Players in Europe
6.3 Europe Neuroscience Antibodies and Assays Market Size by Type
6.4 Europe Neuroscience Antibodies and Assays Market Size by Application

7 China
7.1 China Neuroscience Antibodies and Assays Market Size (2014-2019)
7.2 Neuroscience Antibodies and Assays Key Players in China
7.3 China Neuroscience Antibodies and Assays Market Size by Type
7.4 China Neuroscience Antibodies and Assays Market Size by Application

8 Japan
8.1 Japan Neuroscience Antibodies and Assays Market Size (2014-2019)
8.2 Neuroscience Antibodies and Assays Key Players in Japan
8.3 Japan Neuroscience Antibodies and Assays Market Size by Type
8.4 Japan Neuroscience Antibodies and Assays Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Neuroscience Antibodies and Assays Market Size (2014-2019)
9.2 Neuroscience Antibodies and Assays Key Players in Southeast Asia
9.3 Southeast Asia Neuroscience Antibodies and Assays Market Size by Type
9.4 Southeast Asia Neuroscience Antibodies and Assays Market Size by Application

10 India
10.1 India Neuroscience Antibodies and Assays Market Size (2014-2019)
10.2 Neuroscience Antibodies and Assays Key Players in India
10.3 India Neuroscience Antibodies and Assays Market Size by Type
10.4 India Neuroscience Antibodies and Assays Market Size by Application

11 Central & South America
11.1 Central & South America Neuroscience Antibodies and Assays Market Size (2014-2019)
11.2 Neuroscience Antibodies and Assays Key Players in Central & South America
11.3 Central & South America Neuroscience Antibodies and Assays Market Size by Type
11.4 Central & South America Neuroscience Antibodies and Assays Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher
12.1.1 Thermo Fisher Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neuroscience Antibodies and Assays Introduction
12.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.1.5 Thermo Fisher Recent Development
12.2 Abcam
12.2.1 Abcam Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neuroscience Antibodies and Assays Introduction
12.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.2.5 Abcam Recent Development
12.3 Bio-Rad
12.3.1 Bio-Rad Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neuroscience Antibodies and Assays Introduction
12.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.3.5 Bio-Rad Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neuroscience Antibodies and Assays Introduction
12.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Cell Signaling Technology
12.5.1 Cell Signaling Technology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neuroscience Antibodies and Assays Introduction
12.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.5.5 Cell Signaling Technology Recent Development
12.6 Genscript
12.6.1 Genscript Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neuroscience Antibodies and Assays Introduction
12.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.6.5 Genscript Recent Development
12.7 Rockland Immunochemicals
12.7.1 Rockland Immunochemicals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neuroscience Antibodies and Assays Introduction
12.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.7.5 Rockland Immunochemicals Recent Development
12.8 BioLegend
12.8.1 BioLegend Company Details
12.8.2 Company Description and Business Overview
12.8.3 Neuroscience Antibodies and Assays Introduction
12.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.8.5 BioLegend Recent Development
12.9 Santa Cruz Biotechnology
12.9.1 Santa Cruz Biotechnology Company Details
12.9.2 Company Description and Business Overview
12.9.3 Neuroscience Antibodies and Assays Introduction
12.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.9.5 Santa Cruz Biotechnology Recent Development
12.10 Roche
12.10.1 Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Neuroscience Antibodies and Assays Introduction
12.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2014-2019)
12.10.5 Roche Recent Development
12.11 Siemens

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details